1. Lawson PA, Citron DM, Tyrrell KL, et al. Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prevot 1938. Anaerobe 2016;40:95-99. doi: 10.1016/j.anaerobe.2016.06.008
2. C difficile-a rose by any other name. Lancet Infectious Diseases 2019;19(5):449-49. doi: 10.1016/j.anaerobe.2016.06.008
3. Gao T, He B, Pan Y, et al. Association of Clostridium difficile infection in hospital mortality: A systematic review and meta-analysis. American Journal of Infection Control 2015;43(12):1316-20. doi: 10.1016/j.ajic.2015.04.209
4. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. Available at https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
5. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018 doi: 10.1093/cid/cix1085 [published Online First: 2018/02/15]
6. Verheyen E, Dalapathi V, Arora S, et al. High 30-day readmission rates associated with Clostridium difficile infection. American Journal of Infection Control 2019;47(8):922-27. doi: 10.1016/j.ajic.2019.01.007
7. Lurienne L, Bandinelli PA, Galvain T, et al. Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey. J Patient Rep Outcomes 2020;4(1):14. doi: 10.1186/s41687-020-0179-1 [published Online First: 2020/02/19]
8. Dayananda P, Wilcox MH. Irritable bowel syndrome following Clostridium difficile infection. Current Opinion in Gastroenterology 2019;35(1):1-5. doi: 10.1097/mog.0000000000000490
9. Gerding DN, Muto CA, Owens RC, Jr. Measures to control and prevent Clostridium difficile infection. Clinical Infectious Diseases 2008;46:S43-S49. doi: 10.1086/521861
10. Kuijper EJ, Coignard B, Tull P, et al. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical Microbiology and Infection 2006;12:2-18. doi: 10.1111/j.1469-0691.2006.01580.x
11. Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust: Commission for Healthcare Audit and Inspection, 2006.
12. National Department of Health, South Africa. Essential Drugs Programme. Hospital level (Adults) Standard Treatment Guidelines and Essential Medicines List. 5th ed. 2019.
13. Debast SB, Bauer MP, Kuijper EJ, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014;20 Suppl 2:1-26. doi: 10.1111/1469-0691.12418
14. Legenza L, Barnett S, Rose W, et al. Clostridium difficile infection perceptions and practices: a multicenter qualitative study in South Africa. Antimicrobial Resistance and Infection Control 2018;7 doi: 10.1186/s13756-018-0425-y
15. Legenza L, Barnett S, Rose W, et al. Epidemiology and outcomes of Clostridium difficile infection among hospitalised patients: results of a multicentre retrospective study in South Africa. BMJ Glob Health 2018;3(4):e000889. doi: 10.1136/bmjgh-2018-000889 [published Online First: 2018/07/31]
16. Mitchell BG, Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrobial Resistance and Infection Control 2012;1 doi: 10.1186/2047-2994-1-20
17. Balsells E, Shi T, Leese C, et al. Global burden of Clostridium difficile infections: a systematic review and meta-analysis. Journal of Global Health 2019;9(1) doi: 10.7189/jogh.09.010407
18. Curcio D, Cane A, Fernandez FA, et al. Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis. Infect Dis Ther 2019;8(1):87-103. doi: 10.1007/s40121-019-0231-8 [published Online First: 2019/01/20]
19. Keeley AJ, Beeching NJ, Stott KE, et al. Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa. Malawi Med J 2016;28(2):66-69. doi: 10.4314/mmj.v28i2.8 [published Online First: 2016/11/30]
20. Fogarty International Center. Frequently Asked Questions about Implementation Science. 2013. http://www.fic.nih.gov/News/Events/implementation-science/Pages/faqs.aspx.
21. Bauer MS, Damschroder L, Hagedorn H, et al. An introduction to implementation science for the non-specialist. BMC Psychol 2015;3:32. doi: 10.1186/s40359-015-0089-9 [published Online First: 2015/09/16]
22. Fisher ES, Shortell SM, Savitz LA. Implementation Science: A Potential Catalyst for Delivery System Reform. JAMA 2016;315(4):339-40. doi: 10.1001/jama.2015.17949
23. Koczwara B, Birken SA, Perry CK, et al. How Context Matters: A Dissemination and Implementation Primer for Global Oncologists. J Glob Oncol 2016;2(2):51-55. doi: 10.1200/JGO.2015.001438 [published Online First: 2016/01/20]
24. Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 2009;4:50. doi: 10.1186/1748-5908-4-50 [published Online First: 2009/08/07]
25. Ridde V. Need for more and better implementation science in global health. BMJ Glob Health 2016;1(2):e000115. doi: 10.1136/bmjgh-2016-000115 [published Online First: 2016/08/08]
26. Ridde V, Pérez D, Robert E. Using implementation science theories and frameworks in global health. BMJ Glob Health 2020;5(4):e002269. doi: 10.1136/bmjgh-2019-002269 [published Online First: 2020/04/16]
27. Means AR, Kemp CG, Gwayi-Chore MC, et al. Evaluating and optimizing the consolidated framework for implementation research (CFIR) for use in low- and middle-income countries: a systematic review. Implementation Science 2020;15(1) doi: 10.1186/s13012-020-0977-0
28. Gimbel S, Rustagi AS, Robinson J, et al. Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research. J Acquir Immune Defic Syndr 2016;72 Suppl 2(Suppl 2):S108-16. doi: 10.1097/qai.0000000000001055 [published Online First: 2016/06/30]
29. Soi C, Gimbel S, Chilundo B, et al. Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR). Implement Sci 2018;13(1):151. doi: 10.1186/s13012-018-0846-2 [published Online First: 2018/12/13]
30. Rodriguez VJ, LaCabe RP, Privette CK, et al. The Achilles' heel of prevention to mother-to-child transmission of HIV: Protocol implementation, uptake, and sustainability. Sahara j 2017;14(1):38-52. doi: 10.1080/17290376.2017.1375425 [published Online First: 2017/09/20]
31. Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci 2015;10:21. doi: 10.1186/s13012-015-0209-1 [published Online First: 2015/02/12]
32. Taylor MJ, McNicholas C, Nicolay C, et al. Systematic review of the application of the plan-do-study-act method to improve quality in healthcare. BMJ Qual Saf 2014;23(4):290-8. doi: 10.1136/bmjqs-2013-001862 [published Online First: 2013/09/11]
33. Sulla V, Zikhali P. Overcoming Poverty and Inequality in South Africa : An Assessment of Drivers, Constraints and Opportunities (English). 2018. Washington, D.C.: World Bank Group. http://documents.worldbank.org/curated/en/530481521735906534/Overcoming-Poverty-and-Inequality-in-South-Africa-An-Assessment-of-Drivers-Constraints-and-Opportunities.
34. Alvarez-Uria G, Gandra S, Laxminarayan R. Poverty and prevalence of antimicrobial resistance in invasive isolates. Int J Infect Dis 2016;52:59-61. doi: 10.1016/j.ijid.2016.09.026 [published Online First: 2016/10/04]
35. Statistics South Africa. General Household Survey 2017, Statistical release P0318. Pretoria, South Africa: Statistics South Africa; 2017a. Available at: https://www.statssa.gov.za/publications/P0318/P03182017.pdf.
36. Cummins P. Access to health care in the Western Cape. Lancet 2002;360:S49-S50. doi: 10.1016/s0140-6736(02)11820-4
37. Mayosi BM, Flisher AJ, Lalloo UG, et al. The burden of non-communicable diseases in South Africa. Lancet 2009;374(9693):934-47. doi: 10.1016/S0140-6736(09)61087-4 [published Online First: 2009/08/24]
38. Centre on Global Health Security. Review of Progress on Antimicrobial Resistance. 2019. https://www.chathamhouse.org/sites/default/files/publications/research/2019-10-04-AMR.pdf.
39. Rubin MA, Jones M, Leecaster M, et al. A simulation-based assessment of strategies to control Clostridium difficile transmission and infection. PLoS One 2013;8(11):e80671. doi: 10.1371/journal.pone.0080671 [published Online First: 2013/11/28]
40. Abbett SK, Yokoe DS, Lipsitz SR, et al. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30(11):1062-9. doi: 10.1086/644757 [published Online First: 2009/09/16]
41. Barker AK, Ngam C, Musuuza JS, et al. Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles. Infect Control Hosp Epidemiol 2017;38(6):639-50. doi: 10.1017/ice.2017.7 [published Online First: 2017/03/28]
42. Legenza L, Barnett S, Rose W, et al. Clostridium difficile infection perceptions and practices: a multicenter qualitative study in South Africa. Antimicrob Resist Infect Control 2018;7:125. doi: 10.1186/s13756-018-0425-y [published Online First: 2018/11/06]
43. Lynch EA, Mudge A, Knowles S, et al. "There is nothing so practical as a good theory": a pragmatic guide for selecting theoretical approaches for implementation projects. Bmc Health Services Research 2018;18 doi: 10.1186/s12913-018-3671-z
44. Boaz A, Hanney S, Borst R, et al. How to engage stakeholders in research: design principles to support improvement. Health Res Policy Syst 2018;16(1):60. doi: 10.1186/s12961-018-0337-6 [published Online First: 2018/07/11]
45. National Department of Health, South Africa. Essential Drugs Programme. Hospital level (Adults) Standard Treatment Guidelines and Essential Medicines List. 4th ed. 2015.
46. UNAIDS AIDSinfo. People Living with HIV - all ages. 1990-2019. https://aidsinfo.unaids.org/. Accessed April 5, 2021.
47. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV 2019;6(12):e831-e59. doi: 10.1016/S2352-3018(19)30196-1 [published Online First: 2019/08/19]
48. Hall P. Interprofessional teamwork: professional cultures as barriers. Journal of interprofessional care 2005;19 Suppl 1:188-96.
49. Claramita M, Riskiyana R, Susi AP, et al. Interprofessional communication in a socio-hierarchical culture: development of the TRI-O guide. Journal of Multidisciplinary Healthcare 2019;12:191-204. doi: 10.2147/jmdh.s196873
50. Jordans E, Ng'weno B, Spencer-Oatey H. Developing Global Leaders: Insights from African Case Studies: Springer International Publishing 2019.
51. Susilo AP, Van Dalen J, Scherpbier A, et al. Nurses' roles in informed consent in a hierarchical and communal context. Nursing Ethics 2013;20(4):413-25. doi: 10.1177/0969733012468467
52. Etheredge HR, Penn C, Watermeyer J. Interprofessional communication in organ transplantation in Gauteng Province, South Africa. Samj South African Medical Journal 2017;107(7):615-20. doi: 10.7196/SAMJ.2017.v107i7.12355
53. Nembhard IM, Edmondson AC. Making it safe: The effects of leader inclusiveness and professional status on psychological safety and improvement efforts in health care teams. Journal of Organizational Behavior 2006;27(7):941-66. doi: 10.1002/job.413
54. Kononowech J, Hagedorn H, Hall C, et al. Mapping the organizational readiness to change assessment to the Consolidated Framework for Implementation Research. Implement Sci Commun 2021;2(1):19. doi: 10.1186/s43058-021-00121-0 [published Online First: 2021/02/13]
55. Kabukye JK, de Keizer N, Cornet R. Assessment of organizational readiness to implement an electronic health record system in a low-resource settings cancer hospital: A cross-sectional survey. Plos One 2020;15(6) doi: 10.1371/journal.pone.0234711
56. Miake-Lye IM, Delevan DM, Ganz DA, et al. Unpacking organizational readiness for change: an updated systematic review and content analysis of assessments. Bmc Health Services Research 2020;20(1) doi: 10.1186/s12913-020-4926-z
57. Pellecchia M, Mandell DS, Nuske HJ, et al. Community-academic partnerships in implementation research. Journal of Community Psychology 2018;46(7):941-52. doi: 10.1002/jcop.21981
58. Greenhalgh T, Robert G, Macfarlane F, et al. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 2004;82(4):581-629. doi: 10.1111/j.0887-378X.2004.00325.x
59. Gustafson DH, Sainfort F, Eichler M, et al. Developing and testing a model to predict outcomes of organizational change. Health Services Research 2003;38(2):751-76. doi: 10.1111/1475-6773.00143
60. Department: Government Communication and Information System. Republic of South Africa. Tender Procedures. https://www.gcis.gov.za/content/about-us/procurement/procedure. Accessed April 5, 2021.
61. Damschroder LJ, Lowery JC. Evaluation of a large-scale weight management program using the consolidated framework for implementation research (CFIR). Implementation Science 2013;8 doi: 10.1186/1748-5908-8-51
62. Kirk MA, Kelley C, Yankey N, et al. A systematic review of the use of the Consolidated Framework for Implementation Research. Implementation Science 2016;11 doi: 10.1186/s13012-016-0437-z